Rein Therapeutics, Inc. (RNTX)
Last updated: 2026-11-16 16:53:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Rein Therapeutics, Inc. (RNTX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.40, with a market capitalization of $47.63M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.29 to $2.10. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$47.63M | |
$0.50 | |
$0.62 | |
$0.29 | |
$0.55 | |
4.93M | |
434.79K | |
-- | |
$2.10 | |
$0.29 | |
-- | |
-- |
Rein Therapeutics, Inc. (RNTX) Stock Price Today
Rein Therapeutics, Inc. (RNTX) is currently trading at $0.40 as of 2026-11-16 16:49:00, down 25.09% ($0.14) from the previous close of $0.55
During today's regular trading session, RNTX has traded between $0.29 and $0.62, with a trading volume of 4.93M shares. The current price is near the middle of today's range.
Why Is RNTX Stock Down Today?
RNTX is down 1.18% during regular trading hours.
Rein Therapeutics shares are trading lower after the company reported twelve-week interim data from the RENEW Phase 2 trial of LTI-03 for Idiopathic Pulmonary Fibrosis and reported Q3 financial results.
Rein Therapeutics, Inc. (RNTX) 7-Day Stock Price Change
Over the past seven days, Rein Therapeutics, Inc. (RNTX) moved from $0.61 to $0.40, representing a decline of 33.99% ($0.21).
The stock traded between $0.29 and $0.66 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 386.52 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
RNTX 52-Week Price Position
Position in Range: 6.1%
RNTX is currently trading at $0.40, placing it 6.1% of the way from its 52-week low of $0.29 to its 52-week high of $2.10. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Rein Therapeutics, Inc. (RNTX)?
Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments. Its pipeline includes: LTI-03, a peptide, for placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis, that has demonstrated the ability to protect healthy lung epithelial cells and reduce pro-fibrotic signaling; LTI-01, a proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment.
Rein Therapeutics, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 10 |
| Exchange | NASDAQ |
| Company Website |
RNTX News
Latest news related to Rein Therapeutics, Inc. and RNTX stock.
- Read Full Article
- Read Full Article
Rein Therapeutics Reports Preliminary 12-Week Blinded Phase 2 RENEW Data For LTI-03 In IPF Patients; Study Achieves 75% Enrollment, With 90 Patients Randomized To Date; On Track To Report Topline Data In 2027
33% of evaluable patients demonstrated improvement over baseline in forced vital capacity (FVC) at Week 12From baseline, change in FVC ranged from an improvement of 338 ml to a decline of 349 ml at Week 12Low
- Read Full Article
Rein Therapeutics Q3 EPS $(0.06) Beats $(0.10) Estimate
Rein Therapeutics (NASDAQ:RNTX) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.10) by 40 percent. This is a 71.43 percent increase over losses of $(0.21) per share from
Ways to Trade RNTX at MEXC
How to Buy Rein Therapeutics, Inc. (RNTX) Stock on MEXC
Eligible investors can buy real shares of Rein Therapeutics, Inc. (RNTX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Rein Therapeutics, Inc. (RNTX) stock price today?
2.Is RNTX stock going up or down today?
3.What is RNTX pre-market price?
4.What is RNTX after-hours price?
5.Is RNTX stock trading now?
6.Where does RNTX sit relative to its 52-week high and low?
7.What sector is Rein Therapeutics, Inc. in?
8.What is Rein Therapeutics, Inc.'s market capitalization and where is it listed?
9.How is RNTX valued in terms of P/E ratio and EPS?
10.Does Rein Therapeutics, Inc. pay a dividend?
Explore More US Stocks
Compliance Disclosure and Data Source
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to RNTX, including Stocks, Tokenized Stocks, and Stock Futures.
Disclaimer
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Search Stocks
RNTX Stock Calculator
Estimate the value between RNTX shares and USD.
RNTX Shares to USD
1.00 RNTX shares = 0.404 USD
Calculations are estimates based on the latest available price and are for reference only.


